Rodney Parsons

Executive Director

Bristol-Myers Squibb Co

Rodney Parsons is currently chair of our Mutagenic Impurity Assessment Committee which address all mutagenic impurities including nitrosamine impurities. He is an organic chemist by training and am responsible for the Chemical Technologies group with Chemical Process Development.

SPEAKED ABOUT:

Genotoxic-Impurities-Nitrosamines-Beyond

4th Annual Genotoxic Impurities Summit: Nitrosamines & Beyond 2024

Pharma

December 4, 2024

Meeting with subject matter experts to evaluate different points of view on how to solve the problems associated with mutagenic impurities. Recording of 2 days event sessions [13 video sessions].

Expired

Online

DAY 1: December 4^th, 2024

SESSION: Addressing NDSRI Risks

◆ Recent HA focus on NDSRI risk has required us to reassess the end to end portfolio to address any concerns from the nitrosamine impurities.

LEARN MORE

Genotoxic
Speaker